When Hepatitis B Virus Meets Interferons
Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017). Interferon (IFN; including pegylated IFN) is an approved anti-HBV drug that not only exerts direct a...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018-07-01
|
| Serier: | Frontiers in Microbiology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01611/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
